Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Phase III clinical data from SCENESSE trials (the FDA-approved formulation of afamelanotide) demonstrated that patients with erythropoietic protoporphyria achieved clinically meaningful photoprotection after 60 days of sustained drug delivery via controlled-release implant
This process attenuates actinmyosin interactions, thereby promoting vasodilation
It is produced with glutathione, vitamin C, grape seed extract, alpha lipoic acid, l-lysine, vitamin E, and biotin
Most noteworthy, it has FDA approval
In addition, bioavailability issues with oral chemotherapy can stem from the patients loss of appetite, and delayed gastric emptying can alter drug absorption
As of 2021, use of GLP-1 medications has surged, with many users taking them for weight loss rather than type 2 diabetes management
